Drug intelligence / Profile preview

qijia fuzheng rougan

Development stage
Preclinical
Lead developer
Beijing University of Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Qijia Fuzheng Rougan is a traditional Chinese medicine (TCM) compound formula primarily investigated for its effects on liver fibrosis and related hepatic diseases. The formulation consists of multiple herbal components designed to regulate immune responses and inhibit fibrogenesis in the liver. Mechanistically, it ameliorates extracellular matrix (ECM) deposition in hepatic fibrosis by modulating the JAK1/STAT6-microRNA-23a feedback loop in macrophage M2 polarization[1][4][6]. It also inhibits aberrant activation of mTORC1 signaling to reverse macrophage M1 to M2 polarization and reduces pro-inflammatory cytokines such as CCL2, CCL5, IL-1β, IL-6, inducible nitric oxide synthase (iNOS), and TNF-α[3]. The formula further decreases markers of liver fibrosis including collagen I/III, lysyl oxidase, TIMP1, α-smooth muscle actin (α-SMA), transforming growth factor β (TGF-β), and hypoxia-inducible factor 1α through pathways like PI3K/AKT[3]. Its primary indication is for the treatment or mitigation of hepatic fibrosis.

Other names
qijia fuzheng rouganQijia Rougan formulaQijia Rougan decoctionQJRG
02

Targets

JAK1 (Janus kinase 1)Mechanistic target of rapamycin complex 1PI3K (Phosphoinositide-3-kinase regulatory subunit 6)STAT6 (Signal Transducer and Activator of Transcription 6)

Beyond the preview

Go deeper on qijia fuzheng rougan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on qijia fuzheng rougan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call